Filters
Filters
Anti-Tumor
| Image | Part # | Description | Product | Stock | RFQ | |
|---|---|---|---|---|---|---|
![quality [#varpname#] factory](/images/load_icon.gif){kind=icon}
|
1-Amino-2-methylpropan-2-ol (2854-16-2) |
CAS: 2854-16-2; Enasidenib manufacturer; Enasidenib intermediate
|
|
In Stock
|
|
|
|
|
4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine (1446507-68-1) |
CAS: 1446507-68-1; Enasidenib manufacturer; Enasidenib intermediate
|
|
In Stock
|
|
|
|
|
Enasidenib mesylate (1650550-25-6) |
CAS: 1650550-25-6; Enasidenib manufacturer; Enasidenib API; Anti-tumor
|
|
In Stock
|
|
|
|
|
Niraparib (free free alkali form) (1038915-60-4) |
CAS: 1038915-60-4; Niraparib manufaturer; Niraparib intermediate
|
|
In Stock
|
|
|
|
|
Niraparib tosylate monohydrate (1613220-15-7) |
CAS: 1613220-15-7; Niraparibmanufacturer; Niraparib API; Anti-tumor
|
|
In Stock
|
|
|
|
|
Methyl 3-formyl-2-nitrobenzoate (138229-59-1) |
CAS: 138229-59-1; Niraparib manufaturer; Niraparib intermediate
|
|
In Stock
|
|
|
|
|
(S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate (1171197-20-8) |
CAS: 1171197-20-8; Niraparib manufaturer; Niraparib intermediate
|
|
In Stock
|
|
|
|
|
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4) |
CAS: 1022150-12-4; Ibrutinib manufaturer; Ibrutinib intermediate
|
|
In Stock
|
|
|
|
|
(S)-1-Boc-3-hydroxypiperidine (143900-44-1) |
CAS: 143900-44-1; Ibrutinib manufaturer; Ibrutinib intermediate
|
|
In Stock
|
|
|
|
|
5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine (330786-24-8) |
CAS: 330786-24-8; Ibrutinib manufaturer; Ibrutinib intermediate
|
|
In Stock
|
|
|
|
|
Ibrutinib (936563-96-1) |
CAS: 936563-96-1; Ibrutinib manufacturer; Ibrutinib API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
5-aMino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile (330792-70-6) |
CAS: 330792-70-6; Ibrutinib manufaturer; Ibrutinib intermediate
|
|
In Stock
|
|
|
|
|
4-Amino-2-trifluoromethylpyridine (147149-98-2) |
CAS: 147149-98-2; Enasidenib manufacturer; Enasidenib intermediate
|
|
In Stock
|
|
|
|
|
6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione (1446507-38-5) |
CAS: 1446507-38-5; Enasidenib manufacturer; Enasidenib intermediate
|
|
In Stock
|
|
|
|
|
(R)-tert-Butyl 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate (1022150-11-3) |
CAS: 1022150-11-3; Ibrutinib manufaturer; Ibrutinib intermediate
|
|
In Stock
|
|
|
|
|
3-cyclopentylacrylonitrile (591769-05-0) |
CAS: 591769-05-0; Ruxolitinib manufacturer; Ruxolitinib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine (941685-26-3) |
CAS: 941685-26-3; Ruxolitinib manufacturer; Ruxolitinib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Ruxolitinib Phosphate (1092939-17-7) |
CAS: 1092939-17-7; Ruxolitinib manufacturer; Ruxolitinib API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Relugolix (737789-87-6) |
CAS: 737789-87-6; anti-tumor ; relugolix prostate cancer; relugolix injection
|
|
In Stock
|
|
|
|
|
5-Nitrothiophene-2-carboxylicacid (6317-37-9) |
CAS: 6317-37-9; anti-tumor ; thymidylate synthase; polyglutamate species
|
|
In Stock
|
|
|
|
|
5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid (131052-68-1) |
CAS: 131052-68-1; anti-tumor ; thymidylate synthase; polyglutamate species
|
|
In Stock
|
|
|
|
|
6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one (112888-43-4) |
CAS: 112888-43-4; anti-tumor ; thymidylate synthase; polyglutamate species
|
|
In Stock
|
|
|
|
|
Raltitrexed (112887-68-0) |
CAS:112887-68-0; anti-tumor ; thymidylate synthase; polyglutamate species
|
|
In Stock
|
|
|
|
|
Pralatrexate (52853-40-4) |
CAS: 52853-40-4; anti-tumor ; pralatrexate t cell lymphoma
|
|
In Stock
|
|
|
|
|
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide (52853-40-4) |
CAS: 52853-40-4; anti-tumor ; pralatrexate t cell lymphoma; intermediate
|
|
In Stock
|
|
|
|
|
Pomalidomide (19171-19-8) |
CAS: 19171-19-8; Pomalidomide manufacturer; Pomalidomide API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
2,6-Dioxopiperidine-3-ammonium chloride (24666-56-6) |
CAS: 24666-56-6; Pomalidomide manufacturer; Pomalidomide intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Methotrexate (59-05-2) |
CAS: 59-05-2; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
Pyrimidinetetramine sulfate (5392-28-9) |
CAS: 5392-28-9; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
1,1,3-Tribromoacetone (3475-39-6) |
CAS: 3475-39-6; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride (73978-41-3) |
CAS: 73978-41-3; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
2,4-diamino-6-(hydroxymethyl)-pteridine (945-24-4) |
CAS: 945-24-4; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
6-(chloromethyl)pteridine-2,4-diamine monohydrochloride (82778-08-3) |
CAS: 82778-08-3; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
4-(Methylamino)benzoic acid (10541-83-0) |
CAS: 10541-83-0; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
Methotrexate Disodium Salt (7413-34-5) |
CAS: 7413-34-5; anti-tumor ; arthritis; rheumatoid
|
|
In Stock
|
|
|
|
|
Leucovorin calcium (1492-18-8) |
CAS: 1492-18-8; anti-tumor ; Leucovorin calcium
|
|
In Stock
|
|
|
|
|
Levofolinate Calcium (80433-71-2) |
CAS: 80433-71-2; anti-tumor ; Levofolinate Calcium
|
|
In Stock
|
|
|
|
|
Methyl 2-bromomethyl-3-nitrobenzoate (98475-07-1) |
CAS: 98475-07-1; Lenalidomide manufacturer; Lenalidomide intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one (18048-64-1) |
CAS: 18048-64-1; Eltrombopag olamine manufacturer; Eltrombopag olamine intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Carfilzomib (868540-17-4) |
CAS: 868540-17-4; anti-tumor ; multiple myeloma carfilzomib
|
|
In Stock
|
|
|
|
|
N-isopropyl-2-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetamide (2121561-39-3) |
CAS: 2121561-39-3; Belumosudil mesylate manufacturer; Belumosudil mesylate intermediate
|
|
In Stock
|
|
|
|
|
Belumosudil mesylate (2109704-99-4) |
CAS: 2109704-99-4; Belumosudil mesylate manufacturer; Belumosudil mesylate API
|
|
In Stock
|
|
|
|
|
Eltrombopag Olamine (496775-62-3) |
CAS: 496775-62-3; Eltrombopag olamine manufacturer; Eltrombopag olamine API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
3-bromo-2-methoxyaniline (116557-46-1) |
CAS: 116557-46-1; Eltrombopag olamine manufacturer; Eltrombopag olamine intermediate; Anti-Tumor
|
|
|
|
|
|
|
3-amino-2-hydroxy-biphenyl-3-carboxylic acid (376608-65-0) |
CAS: 376608-65-0; Eltrombopag olamine manufacturer; Eltrombopag olamine intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) |
CAS: 179324-87-9; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
2,6-Dioxopiperidine-3-ammonium chloride (24666-56-6) |
CAS: 24666-56-6; Lenalidomide manufacturer; Lenalidomide intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Lenalidomide (191732-72-6) |
CAS: 191732-72-6; Lenalidomide manufacturer; Lenalidomide API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) |
CAS: 667403-46-5; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Ixazomib Citrate (1201902-80-8) |
CAS: 1201902-80-8; Ixazomib manufacturer; Ixazomib API; Ixazomib proteasome inhibitor; Anti-Tumor
|
|
In Stock
|
|
1
